OVACE Plus 100 mg/mL (Sulfacetamide Sodium LIQUID) 100 mg/mL

OVACE Plus 100 mg/mL is a topical liquid solution containing sulfacetamide sodium. It is commonly used for skin conditions and is available in a 355 mL bottle. This product is manufactured by Mission Pharmacal Company in the USA.

Strength

100 mg/mL

Pack Size

355 mL in 1 BOTTLE, PLASTIC (0178-0490-12)

Manufacturer / TM Owner

Mission Pharmacal Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OVACE Plus 100 mg/mL is typically used for the treatment of various skin conditions. Sulfacetamide sodium, the active ingredient, is often applied to the skin to help manage bacterial infections and promote healing. This topical solution is designed to be gentle on the skin while providing targeted relief.

Side Effects

When applied topically, OVACE Plus 100 mg/mL may help reduce redness, swelling, and irritation associated with skin infections. Users often notice improved skin appearance and reduced discomfort over time. However, individual results may vary.

Precautions & Warnings

Before using OVACE Plus 100 mg/mL, it is important to read the label instructions carefully. Avoid contact with eyes and mucous membranes. If irritation occurs, discontinue use and consult a healthcare professional. Keep out of reach of children.

Avoid Interactions

OVACE Plus 100 mg/mL may interact with other topical medications. It is advisable to avoid using other skin products simultaneously unless directed by a healthcare provider. Always inform your healthcare professional about all medications you are currently using.

Frequently Asked Questions

OVACE Plus 100 mg/mL is used for the treatment of various skin conditions, including bacterial infections.

OVACE Plus 100 mg/mL should be applied topically to the affected area as directed by a healthcare professional.

Common side effects may include skin irritation, redness, and dryness. If severe irritation occurs, discontinue use and consult a healthcare professional.

It is advisable to avoid using other skincare products simultaneously unless directed by a healthcare provider.

OVACE Plus 100 mg/mL should be kept out of reach of children. Consult a healthcare professional before use on children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.